Achondroplasia, which affects around one in 20,000 babies, has just one approved treatment: BioMarin’s Voxzogo. However, new investigational treatments are vying to compete in the area.

The designer’s new collaboration spells a return to fashion for the professional polymath. But could it also change the industry?